BIOMAT Database Logo BIOMAT Database Logo

[Therapy of tegumental leishmaniasis]. 1966

R D Azulay

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007897 Leishmaniasis, Mucocutaneous A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms. Leishmaniases, Mucocutaneous,Mucocutaneous Leishmaniases,Mucocutaneous Leishmaniasis
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005664 Furazolidone A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514) Nifurazolidone,Furazol,Furazolidine,Furoxone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000578 Amidines Derivatives of oxoacids RnE(
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000965 Antimony A metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.
D001152 Arsenicals Inorganic or organic compounds that contain arsenic. Arsenic Compounds,Compounds, Arsenic

Related Publications

R D Azulay
[American tegumental leishmaniasis].
January 2006, Revista da Associacao Medica Brasileira (1992),
R D Azulay
[Otorhinolaryngologic localizations of "American tegumental leishmaniasis"].
January 1968, Revue de laryngologie - otologie - rhinologie,
R D Azulay
[Diffuse tegumental leishmaniasis; new clinicopathological & parasitic entity].
January 1958, Revista de sanidad y asistencia social,
R D Azulay
[Localization of secondary lesions of tegumental leishmaniasis americana].
January 1953, Brasil-medico,
R D Azulay
[Origin of American tegumental leishmaniasis in Minas Gerais].
December 1966, Hospital (Rio de Janeiro, Brazil),
R D Azulay
[Therapeutic trials in tegumental American leishmaniasis. II. TWSb].
March 1959, Hospital (Rio de Janeiro, Brazil),
R D Azulay
[Considerations of the epidemiology of tegumental leishmaniasis in Argentina].
March 1952, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau,
R D Azulay
[Amphotericin B in the treatment of American tegumental leishmaniasis].
June 1961, Hospital (Rio de Janeiro, Brazil),
R D Azulay
[Tegumental leishmaniasis in Las Lomitas, Province of Formosa, Argentina, 1992-2001].
January 2002, Medicina,
R D Azulay
[CURRENT STATUS OF KNOWLEDGE OF THE "LEPROMATOID FORM" OF TEGUMENTAL LEISHMANIASIS (TL)].
January 1965, Hospital (Rio de Janeiro, Brazil),
Copied contents to your clipboard!